Roles of ribosome biogenesis disorder in the development of hematopoietic malignancies
Description: In this study, we analyzed the molecular function of DDX41, a DEAD-box type RNA helicase, to elucidate molecular pathogenesis of myeloid malignancies. We performed a comprehensive translation analysis by taking advantage of ribosome-profiling method and found that transcription and translation are only marginally correlate with each other. We also found that ribosome-associated proteins were selectively induced at translation level when the expression of DDX41 was decreased. This is possibly due to the presence of a feedback regulation against the disorder of ribosome biogenesis by DDX41 inhibition/dysfunction, and we assume this newly identified regulation system would be involved in the hematopoiesis and/or leukemogenesis. The results have been compiled into a manuscript and is currently being submitted to a scientific journal.
Amount: ¥4,420,000
Funding type: research
Funder scheme: Grant-in-Aid for Scientific Research (C)
Start date: 2018-04-01
End date: 2021-03-31
Investigator: HIROTAKA MATSUI (lead)
Institution: Kumamoto University
Subfield: Molecular Biology
Domain: Life Sciences
Funded outputs count: 28
Funder award ID: 18K08334
OpenAlex ID: G46312519
